Literature DB >> 31392567

The Zurich Pituitary Score predicts utility of intraoperative high-field magnetic resonance imaging in transsphenoidal pituitary adenoma surgery.

Victor E Staartjes1, Carlo Serra2, Nicolai Maldaner1, Giovanni Muscas3, Oliver Tschopp4, Michael B Soyka5, David Holzmann5, Luca Regli1.   

Abstract

BACKGROUND: It is currently unclear if there are subsets of patients undergoing transsphenoidal surgery (TSS) in which intraoperative high-field magnetic resonance imaging (3T-iMRI) is particularly advantageous. We aimed to investigate whether a radiological grading scale predicts the utility of 3T-iMRI in pituitary adenoma (PA) TSS.
METHODS: From a prospective registry, patients who underwent endoscopic TSS for PA using 3T-iMRI were identified. Adenomas were graded using the Zurich Pituitary Score (ZPS). We assessed improvement after 3T-iMRI in terms of gross total resection (GTR), residual volume (RV), and extent of resection (EOR).
RESULTS: Among 95 patients, rates of conversion to GTR after 3T-iMRI decreased steadily from 33% for grade I to 0% for grade IV adenomas, with a statistically significant conversion rate only for grade I (p = 0.008) and grade II (p < 0.001). All grade I adenomas were completely resected after 3T-iMRI. Median RV change was statistically significant for grades I to III, but not for grade IV (p = 0.625). EOR improvement ranged from a median change of 0.0% (IQR 0.0-4.5%) for grade I to 4.4% (IQR 0.0-9.0%) for grade IV, with a significant improvement only for grades I to III (p < 0.05).
CONCLUSIONS: Interestingly, this study shows that clinical utility of 3T-iMRI is highest in the more "simple" adenomas (ZPS grades I-II) than for the more "complex" ones (ZPS grade III-IV). Grade I adenomas are amenable to GTR if 3T-iMRI is implemented. In grade III adenomas, EOR and RV can be improved to clinically relevant levels. Conversely, in grade IV adenomas, 3T-iMRI may be of limited use.

Entities:  

Keywords:  Extent of resection; Gross total resection; Intraoperative imaging; Magnetic resonance imaging; Outcome prediction; Zurich Pituitary Score

Mesh:

Year:  2019        PMID: 31392567     DOI: 10.1007/s00701-019-04018-9

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors.

Authors:  Elena L Sorba; Victor E Staartjes; Stefanos Voglis; Lazar Tosic; Giovanna Brandi; Oliver Tschopp; Carlo Serra; Luca Regli
Journal:  Neurosurg Rev       Date:  2020-06-24       Impact factor: 3.042

Review 2.  Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis.

Authors:  Victor E Staartjes; Alex Togni-Pogliorini; Vittorio Stumpo; Carlo Serra; Luca Regli
Journal:  Pituitary       Date:  2021-05-04       Impact factor: 4.107

3.  Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.

Authors:  Andrej Paľa; Gwendolin Etzrodt-Walter; Georg Karpel-Massler; Maria Teresa Pedro; Benjamin Mayer; Jan Coburger; Christian Rainer Wirtz; Michal Hlaváč
Journal:  Neurosurg Rev       Date:  2021-12-02       Impact factor: 3.042

4.  Impact of Intraoperative 3-Tesla MRI on Endonasal Endoscopic Pituitary Adenoma Resection and a Proposed New Scoring System for Predicting the Utility of Intraoperative MRI.

Authors:  Masahiro Tanji; Hiroharu Kataoka; Masahiro Kikuchi; Tatsunori Sakamoto; Fumihiko Kuwata; Mami Matsunaga; Takayuki Nakagawa; Yohei Mineharu; Yoshiki Arakawa; Kazumichi Yoshida; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-10-21       Impact factor: 1.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.